ClinicalTrials.Veeva

Menu

Inflammatory Markers in Preeclampsia

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Completed

Conditions

Preeclampsia

Study type

Observational

Funder types

Other

Identifiers

NCT01385813
INFLAMMARPE11

Details and patient eligibility

About

This is an investigation of inflammatory markers in women destined to develop preeclampsia.

Enrollment

129 patients

Sex

Female

Ages

20 to 43 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Caucasian origin

Exclusion criteria

  • Previous diseases e.g. cardiovascular disease, diabetes, hypertension, inflammatory bowel disease, serious organ disease

Trial design

129 participants in 1 patient group

Pregnant women who develop preeclampsia
Description:
pregnant women who develop preeclampsia (n =43) compared to pregnant women fulfilling a normotensive pregnancy (n= 86).

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems